Keith Giles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Keith Giles has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Frank Rigo
Ionis Pharmaceuticals Inc. , 2855 Gazelle Ct., Carlsbad, CA 92010
1 shared publication - Jill Sergesketter Napierala
Department of Neurology (J.S.N., M.N.), University of Texas Southwestern Medical Center, Dallas TX
1 shared publication - Jixue Li
Department of Biochemistry and Molecular Genetics , University of Alabama at Birmingham, 1825 University Blvd., Birmingham, AL 35294 , USA
1 shared publication - Jun Wang
Department of Biochemistry and Molecular Genetics , University of Alabama at Birmingham, 1825 University Blvd., Birmingham, AL 35294 , USA
1 shared publication - Marek Napierala
Department of Neurology, O'Donnell Brain Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA
1 shared publication - Punit P. Seth
Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA
1 shared publication
Latest Publications
- Open Access
- 16 June 2022
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 31 (20) , 3539-3557
Premature transcription termination at the expanded GAA repeats and aberrant alternative polyadenylation contributes to theFrataxintranscriptional deficit in Friedreich’s ataxia
Frataxin deficiency in Friedreich’s ataxia results from transcriptional downregulation of the FXN gene caused by expansion of the intronic trinucleotide guanine-adenine-adenine (GAA) repeats. We used multiple transcriptomic approaches to determine the molecular mechanism of transcription inhibition caused by long GAAs. We uncovered that transcription of FXN in patient cells is prematurely terminated upstream of the expanded repeats leading to the formation of a novel, truncated and stable RNA. This FXN early terminated transcript (FXN-ett) undergoes alternative, non-productive splicing and does not contribute to the synthesis of functional frataxin. The level the FXN-ett RNA directly correlates with the length of the longer of the two expanded GAA tracts. Targeting GAAs with antisense oligonucleotides or excision of the repeats eliminates the transcription impediment, diminishes expression of the aberrant FXN-ett, while increasing levels of FXN mRNA and frataxin. Non-productive transcription may represent a common phenomenon and attractive therapeutic target in diseases caused by repeat-mediated transcription aberrations.
- 16 June 2022
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 31 (20) , 3539-3557
Open AccessPremature transcription termination at the expanded GAA repeats and aberrant alternative polyadenylation contributes to theFrataxintranscriptional deficit in Friedreich’s ataxia
Frataxin deficiency in Friedreich’s ataxia results from transcriptional downregulation of the FXN gene caused by expansion of the intronic trinucleotide guanine-adenine-adenine (GAA) repeats. We used multiple transcriptomic approaches to determine the molecular mechanism of transcription inhibition caused by long GAAs. We uncovered that transcription of FXN in patient cells is prematurely terminated upstream of the expanded repeats leading to the formation of a novel, truncated and stable RNA. This FXN early terminated transcript (FXN-ett) undergoes alternative, non-productive splicing and does not contribute to the synthesis of functional frataxin. The level the FXN-ett RNA directly correlates with the length of the longer of the two expanded GAA tracts. Targeting GAAs with antisense oligonucleotides or excision of the repeats eliminates the transcription impediment, diminishes expression of the aberrant FXN-ett, while increasing levels of FXN mRNA and frataxin. Non-productive transcription may represent a common phenomenon and attractive therapeutic target in diseases caused by repeat-mediated transcription aberrations.